Lertsakulbunlue, Sethapong
Mungthin, Mathirut
Rangsin, Ram
Kantiwong, Anupong
Sakboonyarat, Boonsub
Article History
Received: 14 February 2023
Accepted: 31 March 2023
First Online: 3 April 2023
Declarations
:
: The study was approved by the Medical Department Ethics Review Committee for Research in Human Subjects, Institutional Review Board, RTA (Approval no. S082h/65_Exp), in accordance with international guidelines, including the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines, and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use—Good Clinical Practice (ICH-GCP). Due to the use of secondary data, a waiver of documentation of informed consent was used, and the waiver for informed consent was granted by the Institutional Review Board, RTA Medical Department.
: Not applicable.
: The authors declare no competing interests.